The treatment for Parkinson’s — a degenerative disease hampering movement — may induce disorders such as compulsive gambling, shopping and binge eating in patients, claims a new study.
These impulse control disorders (ICDs) can have disastrous personal, professional and financial consequences if not recognised or treated, researchers from Loyola University Chicago in the US said.
A previous study found that approximately 14% of Parkinson’s disease patients experience at least one ICD. The disorders are more common in men.
Men are more likely to display hypersexuality and pathological gambling, while women are more likely to exhibit compulsive eating and buying.
Potentially catastrophic consequences include financial ruin, divorce and loss of employment, researchers said.
Patients often lack insight and underestimate the presence and severity of ICDs and related conditions. ICDs are probably more prevalent in Parkinson’s disease patients than previously reported, they said.
The primary risk factor for ICDs is the use of a class of Parkinson’s disease medications called dopamine agonists, which help control tremors and other Parkinson’s symptoms.
These drugs include pramipexole and ropinirole.
Other risk factors include younger age, smoking, alcohol abuse and personality traits such as impulsivity, obsessive-compulsive disorder, depression and anxiety.
Management of ICDs is particularly difficult and no treatment guidelines for ICDs in Parkinson’s patients are available, researchers said.
Treatment should be individualised, and careful selection of specific interventions is critical. Treatments that have been considered include switching, reducing or discontinuing Parkinson’s medications.
Researchers suggest alternative treatment strategies for Parkinson’s disease and medications that may help control ICDs, such as antidepressants, atypical antipsychotics and antiepileptic drugs.
Other potential nondrug treatments include cognitive behavioural therapy and a “brain pacemaker” called deep brain stimulation, researchers said.
The study was published in the journal Expert Review of Neurotherapeutics.
Follow @htlifeandstyle for more.